Sleep aid india – VietNam Breaking News

Volunteers sought for second homegrown COVID-19 vaccine trials hinh anh 1

People, aged from 18-59 and residing in Hanoi , are encouraged to register for human trials of Vietnam’s second COVID-19 vaccine candidate COVIVAC (Photo: VNA)

Hanoi (VNA) – People, aged from 18-59 and residing in Hanoi, can register for human t rials of Vietnam’s second COVID-19 vaccine candidate COVIVAC from March 5 morning.

In the first phase of the trials, 150 healthy volunteers will be injected with two doses of 0.5ml with an interval of 28 days.

They will be divided into five groups, including one group provided with placebo shots, and their health will be closely monitored within 24 hours after injections.

Each volunteer will have their health checked-up eight times in 12 months.

After 43 days since the first phase starts and shows good results, the second phase will be carried out at the medical centre of Thai Binh province’s Vu Thu district, with 300 volunteers.

The homegrown vaccine has been developed by the Nha Trang-based Institute of Vaccines and Medical Biologicals (IVAC) and the Hanoi Medical University since last May, using primary chicken embryo cell culture, a technique the institute used previously to successfully produce seasonal flu vaccines.

COVIVAC has undergone pre-clinical trials in India, the US, and Vietnam, said IVAC Director Dr. Duong Huu Thai, adding that results showed that it satisfies all conditions to be tested on humans.

The vaccine candidate demonstrated high immunogenicity during pre-clinical trials. It was created based on studies of new SARS-CoV-2 strains.

This vaccine is expected to have a price of around 60,000 VND (2.59 USD) per dose./.

VNA

The pair were presented with the Shining Star Achievement in the Research category during an online awards ceremony held at 7 a.m. on December 9.

The Shining Star Achievement in Research award is given in recognition of influential scholarly contributions in any discipline, typically in the form of scholarly journal articles that are published, or alternatively books, book chapters, or other expressions of scholarly collaboration.

Prof. Tran Xuan Bach was born in 1984 and is currently vice head of the Health Economics Department at Hanoi Medical University.

He possesses extensive experience in relation to research, surveillance, and evaluation of global health threats in the Asia-Pacific region. His work has won him numerous international and domestic awards in the past, including the Hopkins Center for AIDS Research’s International Research Award.

He has also published over 300 papers in a number of highly regarded international journals, including The Lancet, Bulletin of the World Health Organization, and AIDS and Behavior.

Most notably, Prof. Bach is the youngest professor in recent decades to work at Johns Hopkins University in the United States, the world leader in terms of public health. According to details released by the university, he has extensive experience in advising various U.N. agencies, international organisations, and governments on issues such as global health and development in Southeast Asia.

Meanwhile, born in 1975 Prof. Tran Thi Ly was previously employed as a lecturer at Hue University, although she is currently working at the Faculty of Arts and Education at Deakin University in Australia.

First arriving in Australia in 2001, Prof. Ly has gone on to produce extensive research on the international education sector, including writing the first English-language book on Vietnamese higher education. She has won more than 30 awards, prizes, scholarships, and grants for research, including the prestigious Australian Research Council (ARC) Future Fellowship for her work on the Australian Government’s New Colombo Plan.

Elsewhere at the event, British national Professor Elspeth Jones was honoured with the North Star Medal for Lifetime Achievement. In addition, Professor Raphael Pangalangan of the Philippines and Yao-Tai Li of Hong Kong were named as the winners in the Rising Star Emerging Scholar Certificate category.